RichardNChannickMD

Pulmonology • Los Angeles, CA

Critical Care Medicine

Associate Professor, Medicine-Massachusetts General Hospital, Harvard Medical School

Join to view full profile

Dr. Channick is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Channick's full profile

Already have an account?

Office
10833 Le Conte Ave
Rm 37-131
Los Angeles, CA 90095

Education & Training

University of California (San Diego) Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1991
UMass Chan Medical SchoolResidency, Internal Medicine, 1984 - 1988
Lewis Katz School of Medicine at Temple UniversityClass of 1984

Certifications & Licensure

CA State Medical License 1988 - 2025
MA State Medical License 1986 - 2020
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Selexipag (ACT-293987) in Pulmonary Arterial Hypertension Start of enrollment: 2009 Dec 01
Completed
Phase 3
Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER Start of enrollment: 2017 Apr 18
Terminated
Phase 3
Effect of iNO in Patients With Submassive and Massive PE Start of enrollment: 2021 Jun 01
Withdrawn
Phase 2

Publications & Presentations

PubMed

Management and outcomes in pulmonary arterial hypertension patients with sepsis.
Spencer Flynn, Haidee Chen, Russell Kerbel, Summer Gupta, Sonia Jasuja
BMC Pulmonary Medicine. 2024-10-28
Association Between Thrombus Histopathology and Hemodynamic Outcomes Among Patients With Chronic Thromboembolic Pulmonary Hypertension Undergoing Pulmonary Endarterect...
Louisa A Mounsey, Daniel Alape Moya, Cameron Wright, Nathaniel Langer, James R Stone
Chest. 2024-10-23
1 citations
Efficacy and safety of selexipag in patients with inoperable or persistent/recurrent CTEPH (SELECT randomised trial).
Nick H Kim, Richard Channick, Marion Delcroix, Michael Madani, Joanna Pepke-Zaba
The European Respiratory Journal. 2024-10-01

Lectures

ACC-Talk: What are the Implications of the 6th World Symposium for the General Cardiologist?
2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
What’s the Most Practical Approach to PAH Risk Stratification for the Clinician?
2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
Pulmonary and Critical Care Medicine
Harvard Medical School ,Department Of Continuing Education, Cambridge, Massachusetts - 4/28/2013

Press Mentions

New Insights and Potential Treatments for Pulmonary HypertensionAugust 21st, 2024
Pulmonary Embolism Treatment Teams Adopted Widely for Complex DiseaseNovember 20th, 2019
I'm Aware That I'm Rare: Richard Channick, MD (180)August 24th, 2018
Join now to see all

Grant Support

Ut-15 + Conventional Therapy In Pulmonary HypertensionNational Center For Research Resources2000–2002
RO 47-0203 In Exercise Capacity, Hemodynamics And QOL Of Pulmonary HypertensionNational Center For Research Resources2000–2002